Status:
COMPLETED
Nebulized Hypertonic Saline for Inpatient Use in COPD
Lead Sponsor:
OhioHealth
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A comparison of albuterol treatments using hypertonic saline (3%) versus standard saline (0.9%) in patients with admitted patients COPD in regard to Modified Borg Dyspnea scale scores after 4 treatmen...
Detailed Description
Hypothesis: A clinically significant difference exists between albuterol treatments with nebulized 3% saline versus standard saline, for improvements in the patient's modified Borg dyspnea score duri...
Eligibility Criteria
Inclusion
- Patients at least 18 years of age
- Admitted to Doctors Hospital with a clinical diagnosis of COPD
- Documented obstruction on spirometry from prior records available at the time of the study.
Exclusion
- Patients younger than 18 years of age
- Spirometry data not available
- History of smoking less than twenty pack-years
- Possibility of other primary cause of the patient's change in dyspnea or cough (e.g. pneumonia, congestive heart failure with pulmonary edema, myocardial infarction)
- Patient is found to have a different primary cause after initial enrollment
- Non-English speaking subjects
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2017
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT02266875
Start Date
October 1 2014
End Date
January 30 2017
Last Update
November 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Doctors Hospital
Columbus, Ohio, United States, 43228